The overall goal of this application is to determine the interplay between the liver and intestine in the regulation of fed-state metabolism with emphasis on bile acid (BA) metabolism. BAs function as physiological detergents to aid digestion of lipid nutrients but also function as signaling molecules that profoundly impact metabolism by activating nuclear and membrane BA receptors and also by mediating induction of intestinal FGF15/19 (human FGF19; mouse FGF15). BAs in excess are toxic so that their levels must be tightly controlled and the BA nuclear receptor FXR plays a key role in this regulation. Despite recent advances, the mechanisms underlying the interplay between the liver and intestine mediated by BAs and FGF15 to regulate BA levels, in particular hepatic expression of Cyp7a1, the rate-limiting BA synthetic enzyme, are not well understood. We have preliminary evidence that FGF15-mediated phosphorylation by Src of FXR plays an important role in this interplay. Based on our preliminary data, we hypothesize that Src phosphorylation of FXR at Tyr-67 is mediated by FGF15 signaling under physiological conditions and that Y67FXR phosphorylation is important for gene-selective transcriptional regulation to reduce liver BA levels and terminate FGF15 signaling. To test this hypothesis, we propose the following Specific Aims: 1) Examine the in vivo role of Src phosphorylation of FXR in regulating BA levels, protecting against hepatobiliary defects in normal mice and in mice challenged with biliary insults, and human relevance by examining FXR and Src and their phosphorylated forms in liver samples from primary cholestasis patients. 2) Define the function and mechanisms of FXR phosphorylation by FGF15- and BA-activated Src in the regulation of BA metabolism and 3) determine the role of FGF15-mediated phosphorylation of FXR, in coordination with PPAR?, in terminating FGF15 signaling. Multiple in vitro and in vivo approaches will be used, including genetic and virally generated mouse models and ChIP-seq genomic analysis to identify FXR binding sites globally in mice treated with FGF19. Our expertise on post-translational modifications of nuclear receptors and transcriptional regulation of BA metabolism uniquely qualifies us to address this important research question of the role of posttranslational phosphorylation of FXR in regulation of BA metabolism. Our proposal will determine the novel function and mechanisms of FGF15- induced phosphorylation of FXR, and provide new potential therapeutics and diagnostic markers for BA- and FGF15-related diseases, including cholestatic liver diseases.

Public Health Relevance

Bile acids (BAs) function as physiological detergents to aid digestion and as signaling molecules that profoundly impact fed-state metabolism, but BA levels in excess are toxic and must be tightly regulated. In this proposal, we examine the role of an intestinal hormone, FGF15, which is induced by BA-activated FXR, in modulating the action of FXR in regulating metabolism in the liver after a meal and how the action of FGF15 is terminated to prevent detrimental long-term effects of FGF15. These studies may reveal new therapeutic targets or diagnostic markers for BA-related liver and intestinal diseases.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Research Project (R01)
Project #
Application #
Study Section
Hepatobiliary Pathophysiology Study Section (HBPP)
Program Officer
Burgess-Beusse, Bonnie L
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Illinois Urbana-Champaign
Schools of Arts and Sciences
United States
Zip Code
Byun, Sangwon; Kim, Dong-Hyun; Ryerson, Daniel et al. (2018) Postprandial FGF19-induced phosphorylation by Src is critical for FXR function in bile acid homeostasis. Nat Commun 9:2590
Seok, Sunmi; Kim, Young-Chae; Byun, Sangwon et al. (2018) Fasting-induced JMJD3 histone demethylase epigenetically activates mitochondrial fatty acid ?-oxidation. J Clin Invest 128:3144-3159
Kim, Young-Chae; Seok, Sunmi; Byun, Sangwon et al. (2018) AhR and SHP regulate phosphatidylcholine and S-adenosylmethionine levels in the one-carbon cycle. Nat Commun 9:540
Baek, Amy E; Yu, Yen-Rei A; He, Sisi et al. (2017) The cholesterol metabolite 27 hydroxycholesterol facilitates breast cancer metastasis through its actions on immune cells. Nat Commun 8:864
Byun, Sangwon; Kim, Young-Chae; Zhang, Yang et al. (2017) A postprandial FGF19-SHP-LSD1 regulatory axis mediates epigenetic repression of hepatic autophagy. EMBO J 36:1755-1769
Kwon, Sanghoon; Seok, Sunmi; Yau, Peter et al. (2017) Obesity and aging diminish sirtuin 1 (SIRT1)-mediated deacetylation of SIRT3, leading to hyperacetylation and decreased activity and stability of SIRT3. J Biol Chem 292:17312-17323
Choi, Sung E; Kwon, Sanghoon; Seok, Sunmi et al. (2017) Obesity-Linked Phosphorylation of SIRT1 by Casein Kinase 2 Inhibits Its Nuclear Localization and Promotes Fatty Liver. Mol Cell Biol 37:
Klionsky, Daniel J (see original citation for additional authors) (2016) Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy 12:1-222
Fu, Ting; Kim, Young-Chae; Byun, Sangwon et al. (2016) FXR Primes the Liver for Intestinal FGF15 Signaling by Transient Induction of ?-Klotho. Mol Endocrinol 30:92-103
Fu, T; Kemper, J K (2016) MicroRNA-34a and Impaired FGF19/21 Signaling in Obesity. Vitam Horm 101:175-96

Showing the most recent 10 out of 25 publications